174 related articles for article (PubMed ID: 29387760)
1. Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib.
Moreno-Arrones OM; Carrillo-Gijon R; Sendagorta E; Rios-Buceta L
JAAD Case Rep; 2018 Mar; 4(2):123-125. PubMed ID: 29387760
[No Abstract] [Full Text] [Related]
2. Severe acute generalized exanthematous pustulosis with toxic epidermal necrolysis-like desquamation: A case series of 8 patients.
Huang S; Ahmed A; Hsu S; Lee J; Motaparthi K
JAAD Case Rep; 2021 Sep; 15():115-122. PubMed ID: 34466647
[No Abstract] [Full Text] [Related]
3. Acute localized exanthematous pustulosis (ALEP) caused by lamotrigine.
Hopkins Z; Frigerio A; Clarke JT
JAAD Case Rep; 2018 Aug; 4(7):645-647. PubMed ID: 30094307
[No Abstract] [Full Text] [Related]
4. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
van Hattem S; Beerthuizen GI; Kardaun SH
Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
[TBL] [Abstract][Full Text] [Related]
5. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
6. Rare and Complicated Overlap of Stevens-Johnson Syndrome and Acute Generalized Exanthematous Pustulosis.
Chowdhury TA; Talib KA; Patricia J; Nye KD; Moosa SA
Cureus; 2021 Jun; 13(6):e15921. PubMed ID: 34336425
[TBL] [Abstract][Full Text] [Related]
7. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
Pakkir Maideen NM; Barakat IR; Jumale AH
Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
[TBL] [Abstract][Full Text] [Related]
8. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
9. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
10. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature.
Peermohamed S; Haber RM
Arch Dermatol; 2011 Jun; 147(6):697-701. PubMed ID: 21690532
[TBL] [Abstract][Full Text] [Related]
11. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
[TBL] [Abstract][Full Text] [Related]
12. Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.
Azib S; Florin V; Fourrier F; Delaporte E; Staumont-Sallé D
Clin Exp Dermatol; 2014 Aug; 39(6):723-5. PubMed ID: 24986490
[TBL] [Abstract][Full Text] [Related]
13. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
[TBL] [Abstract][Full Text] [Related]
15. Acute Generalized Exanthematous Pustulosis Simulating Toxic Epidermal Necrolysis: Overlapping Processes.
García Abellán J; Matarredona Catalá J; Jaen Larrieu A; Valencia Ramírez I
Actas Dermosifiliogr (Engl Ed); 2018 Jun; 109(5):460-462. PubMed ID: 29402393
[No Abstract] [Full Text] [Related]
16. Outpatient management and follow-up recommendations for adverse drug reactions: guidelines for posthospitalization care.
Khanna R; Vaudreuil A; Lake E
Cutis; 2019 May; 103(5):254-256;258. PubMed ID: 31233575
[TBL] [Abstract][Full Text] [Related]
17. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Mustafa SS; Ostrov D; Yerly D
Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
19. Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine.
Lateef A; Tan KB; Lau TC
Clin Rheumatol; 2009 Dec; 28(12):1449-52. PubMed ID: 19727917
[TBL] [Abstract][Full Text] [Related]
20. Ethical considerations in the management of drug severe cutaneous adverse reactions.
Buckey TM; Ferreira AL; Grant-Kels JM
J Am Acad Dermatol; 2024 Jan; ():. PubMed ID: 38224911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
